This guide is intended to provide information for prescribers, radiologists and other HCPs that may be involved in the care of Alzheimer's disease patients being treated with lecanemab about the risk and the management of amyloid related imaging abnormalities (ARIA) and intracerebral haemorrhage (ICH) for patients with early Alzheimer’s disease receiving lecanemab.

This card provides essential safety information for patients, including ARIA and ICH, to share with any HCP they see and includes a section with the contact details of their prescribing physician. The patient alert card should be carried by patients at all times.